P
Patrizio Pezzotti
Researcher at Istituto Superiore di Sanità
Publications - 303
Citations - 12814
Patrizio Pezzotti is an academic researcher from Istituto Superiore di Sanità. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 56, co-authored 260 publications receiving 10698 citations. Previous affiliations of Patrizio Pezzotti include fondazione bruno kessler.
Papers
More filters
Journal ArticleDOI
Antimicrobial resistance: a global multifaceted phenomenon.
TL;DR: This review focuses on antibacterial resistance (ABR), which represents at the moment the major problem, both for the high rates of resistance observed in bacteria that cause common infections and for the complexity of the consequences of ABR.
Journal ArticleDOI
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.
A d'Arminio Monforte,Alessandro Cozzi Lepri,G. Rezza,Patrizio Pezzotti,Andrea Antinori,Andrew N. Phillips,G. Angarano,Vincenzo Colangeli,A. De Luca,Giuseppe Ippolito,L. Caggese,Fabrizio Soscia,Gaetano Filice,Fabrice Gritti,Pasquale Narciso,Umberto Tirelli,Mauro Moroni +16 more
TL;DR: In this paper, the authors evaluated the frequency of discontinuation of the first highly active antiretroviral regimen (HAART) and the factors predictive of discontinuing for toxicity and failure in a population-based cohort of HIV-positive individuals in Italy, naive from antirtrovirals at enrolment.
Journal ArticleDOI
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.
Adriana Ammassari,Rita Murri,Patrizio Pezzotti,Maria Paola Trotta,Laura Ravasio,Patrizio De Longis,Sergio Lo Caputo,Pasquale Narciso,S. Pauluzzi,Giampiero Carosi,Salvatore Nappa,P. Piano,Izzo Cm,Miriam Lichtner,Giovanni Rezza,Antonella d'Arminio Monforte,Giuseppe Ippolito,Mauro Moroni,Albert W. Wu,Andrea Antinori +19 more
TL;DR: In addition to patient characteristics, medication‐related variables, and reasons for nonadherence, patient‐reported symptoms and medication side effects were significantly associated with adherence to HAART.
Journal ArticleDOI
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
Kholoud Porter,Abdel Babiker,Krishnan Bhaskaran,Janet Darbyshire,Patrizio Pezzotti,A. Sarah Walker +5 more
TL;DR: Predicted survival for people with HIV-1 has continued to increase, since the introduction of HAART; however, the importance of age and exposure category as determinants of progression seems to have changed.
Journal ArticleDOI
Reduction in Mortality With Availability of Antiretroviral Therapy for Children With Perinatal HIV-1 Infection
M. De Martino,Pier-Angelo Tovo,Maria Balducci,Luisa Galli,Clara Gabiano,Giovanni Rezza,Patrizio Pezzotti +6 more
TL;DR: Survival of perinatally HIV-infected children improved in 1996-1998 as a result of the introduction of combined antiretroviral therapies, suggesting a causal relationship between decreased risk of death and use of combination therapy.